See also this year's filing and all EDGAR filings for this company.
PDF Report 0001113148_2023_INFINITY_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001113148, INFINITY PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 40,302,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 800,000 |
| 3 | remainder_Assets | 1,049,000 |
| 4 | LiabilitiesCurrent | 13,628,000 |
| 5 | LiabilitiesNoncurrent | 361,000 |
| 6 | remainder_Liabilities | 47,213,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,463,000 |
| 9 | ResearchAndDevelopmentExpense | 32,411,000 |
| 10 | remainder_Expenses | 1,563,000 |
| 11 | remainder_Revenues | 2,593,000 |
| 12 | remainder_NetIncome | 475,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 42,151,000 |
| 1 | Liabilities | 61,202,000 |
| 2 | Expenses | 47,437,000 |
| 3 | Revenues | 2,593,000 |
| 4 | StockholdersEquity | -19,051,000 |
| 5 | NetIncome | -44,369,000 |
| 6 | ComprehensiveNetIncome | -44,369,000 |
| 7 | BaseVar | 76,929,000 |
| 8 | EconomicCapitalRatio | -1.49 |
Edgar->Model Mapping
Feature Distribution
Change over Time
